Publisher: Research Institute for Gastroenterology and Liver Diseases (RIGLD)
  • Register
  • Login

Gastroenterology and Hepatology from Bed to Bench

  • Home
  • Issues
    • Current
    • Archives
  • About
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Privacy Statement
    • Contact
  • For Authors
    • Submissions
    • Author Guidelines
    • Article Processing Charge
    • Peer Review Process
  • Indexing & Abstracting
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol. 19, No. 1 (2026): Continuous Volume
  4. Original Article

March 2026

Time trend and geographical distribution of colorectal cancer incidence before and after COVID-19 pandemic in southern Iran: an interrupted time series analysis

  • Moslem Taheri Soodejani
  • Ali Reza Safarpour
  • Majid Keshavarz
  • Maryam Kazemi
  • Alimohammad Bananzadeh

Gastroenterology and Hepatology from Bed to Bench, , 2 March 2026 , Page 1-8 (e7)
https://doi.org/10.22037/ghfbb.v19i01.3269 Published: 2026-03-02

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Aim: This study aimed to assess the trend and geographical distribution of colorectal cancer (CRC) in Fars province from 2011 to 2024, and its changes during COVID-19.

Background: Research has indicated that the risk of CRC varies significantly across different regions of the world.

Methods: From 2011 to 2024, data from 1,453 CRC patients who were registered in the Shiraz Colorectal Cancer Surgery (SCORCS) program were analyzed. Using R software (v4.2.0), we applied interrupted time series analysis to evaluate the impact of COVID-19 on CRC incidence and mortality. Spatial distribution was examined with ArcGIS (v10.4.1), and Moran's I test was used to determine high- and low-risk regions. A 5% significance level was applied to all analyses.

Results: In this study, 56.2% of the patients were men and 43.8% were women. Most patients (49%) were between 30 and 59 years old. Rectal cancer was slightly more common (57.7%) than colon cancer (41.8%), and only a very small number (less than 0.5%) had both. About half of the patients were classified as T3, and over 80% already had metastasis. At the pandemic onset, both outcomes showed a significant immediate increase, followed by a significant post-pandemic decline in slope. Among the studied areas, Kazerun and Jahrom had the highest incidence rate, while Zarqan and Kazerun showed the highest mortality rate.

Conclusion: This study shows that CRC incidence and mortality declined during COVID-19, likely due to restrictive policies. However, the high rates in some cities of Fars province highlight the need for targeted interventions to reduce the disease burden.

Keywords:
  • Colorectal cancer
  • geographical distribution
  • trend
  • Fars province
  • covid 19
  • PDF

How to Cite

Taheri Soodejani, M., Safarpour, A. R., Keshavarz, M., Kazemi , M., & Bananzadeh , A. (2026). Time trend and geographical distribution of colorectal cancer incidence before and after COVID-19 pandemic in southern Iran: an interrupted time series analysis. Gastroenterology and Hepatology from Bed to Bench, 19(01), 1–8 (e7). https://doi.org/10.22037/ghfbb.v19i01.3269
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

1. American Cancer Society. About Colorectal Cancer. 2024 [updated 1/29/2024. Available from: https://www.cancer.org/cancer/types/colon-rectal-cancer/about.html.

2. Ferlay JEM, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, et al. Absolute numbers, incidence, both sexes, in 2022. Colorectum. Continents. Lyon (France): Global Cancer Observatory: Cancer Today (version 1.1). International Agency for Research On Cancer; 2022 [Available from: https://gco.iarc.fr/today/en/dataviz/pie?mode=population&group_populations=0&cancers=41.

3. Shadmani FK, Ayubi E, Khazaei S, Sani M, Hanis SM, Khazaei S, et al. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study. Epidemiol Health 2017;39:e2017020.

4. Ferlay J EM, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, et al. Fact sheet of Islamic Republic of Iran. Lyon (France): Global Cancer Observatory: Cancer Today (version 1.1). International Agency for Research on Cancer; 2022 [Available from: https://gco.iarc.who.int/today].

5. Kazemi E, Zayeri F, Baghestani A, Bakhshandeh M, Hafizi M. Trends of colorectal cancer incidence, prevalence and mortality in worldwide from 1990 to 2017. Iran J Public Health 2023;52:436.

6. Ferlay J LM, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Estimated numbers from 2022 to 2050, Males and Females, age (0-85+] Lyon (France): Global Cancer Observatory: Cancer Today (version 1.1). 2022 [Available from: https://gco.iarc.fr/tomorrow/en/dataviz/trends?types=0_1&sexes=1_2&mode=cancer&group_populations=0&multiple_populations=0&multiple_cancers=1&cancers=41&populations=364.

7. Pourhoseingholi MA, Najafimehr H, Kavousi A, Pasharavesh L, Khanabadi B. The spatial distribution of colorectal cancer relative risk in Iran: a nationwide spatial study. Gastroenterol Hepatol Bed Bench 2020;13:40.

8. Roshandel G, Motlagh AG. Annual report of iranian national population-based cancer registry (2018). Islamic Republic of Iran: Ministry of Health and Medical Education; 2018.

9. Soodejani MT, Tabatabaei SM, Dehghani A, McFarland W, Sharifi H. Impact of mass screening on the number of confirmed cases, recovered cases, and deaths due to COVID-19 in Iran: An interrupted time series analysis. Arch Iran Med 2020;23:776-81.

10. Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 2017;46:348-55.

11. Safarpour AR, Bananzadeh A, Izadpanah A, Ghahramani L, Tadayon SMK, Bahrami F, et al. Report of 13-year survival of patients with colon and rectal cancers; lessons from Shiraz colorectal cancer surgery registry system of a level three medical center. BMC Surg 2022;22:142.

12. Wu Z, Huang Y, Zhang R, Zheng C, You F, Wang M, et al. Sex differences in colorectal cancer: with a focus on sex hormone–gut microbiome axis. Cell Commun Signal 2024;22:167.

13. Rahimi F, Rezayatmand R, Shojaeenejad J, Tabesh E, Ravankhah Z, Adibi P. Costs and outcomes of colorectal cancer screening program in Isfahan, Iran. BMC Health Serv Res 2023;23:13.

14. Halimi L, Bagheri N, Hoseini B, Hashtarkhani S, Goshayeshi L, Kiani B. Spatial analysis of colorectal cancer incidence in Hamadan Province, Iran: a retrospective cross-sectional study. Appl Spatial Anal Policy 2020;13:293-303.

15. Askarian M, Goli A, Oroei M, Faramarzi H. The geographical clusters of gastrointestinal tract cancer in Fars province, Southern Iran. Int J Prev Med 2014;5:857.

16. Fujita M, Nagashima K, Suzuki K, Kasai T, Hashimoto H, Yamaguchi K, et al. Changes in the number of cancer diagnosis practices due to the COVID-19 pandemic: interrupted time-series analysis using the National Database of Japan. J Cancer Res Clin Oncol 2023;149:6023-33.

17. Decker KM, Feely A, Bucher O, Singh H, Turner D, Lambert P. Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province. Prev Med 2022;155:106961.

18. Ilyas F, Ahmed E, Ali H, Ilyas M, Sarfraz S, Khalid M, et al. Temporal trends in colorectal cancer mortality rates (1999–2022) in the United States. Cancer Rep 2024;7:e2012.

  • Abstract Viewed: 191 times
  • PDF Downloaded: 80 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

GHFBB journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Print ISSN: 2008-2258
Online ISSN: 2008-4234

Support Contact: ghfbb.journal@gmail.com

Powered by OJSPlus